FDA Inspection 1152220 — Regenerative Biologics Inc
The FDA completed an inspection of Regenerative Biologics Inc on September 15, 2021 in Brooklyn, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 15, 2021
- Fiscal Year
- 2021
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Brooklyn, NY (United States)